CP 226,269 |
| Catalog No.GC49569 |
A dopamine D4 receptor agonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 220941-93-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CP 226,269 is a dopamine D4 receptor agonist.1 It induces calcium flux in HEK293 cells co-expressing human dopamine D4, but not D2L or D3, receptors and Gαqo5 (EC50s = 32, >10,000, and 985 nM, respectively). CP 226,269 induces phospholipid methylation in SK-N-MC neuroblastoma cells, which endogenously express dopamine D1 and D4 receptors (EC50 = 2.9 nM).2
1.Moreland, R.B., Nakane, M., Donnelly-Roberts, D., et al.Comparative pharmacology of human dopamine D2-like receptor stable cell lines coupled to calcium flux through Gqo5Biochem. Pharmacol.68(4)761-772(2004) 2.Sharma, A., Kramer, M.L., Wick, P.F., et al.D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophreniaMol. Psychiatry4(3)235-246(1999)
Average Rating: 5 (Based on Reviews and 35 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *